Salivary miRNA profiles identify children with autism spectrum disorder, correlate with adaptive behavior, and implicate ASD candidate genes involved in neurodevelopment
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Autism spectrum disorder (ASD) is a common neurodevelopmental disorder that lacks adequate screening tools, often delaying diagnosis and therapeutic interventions. Despite a substantial genetic component, no single gene variant accounts for >1 % of ASD incidence. Epigenetic mechanisms that include microRNAs (miRNAs) may contribute to the ASD phenotype by altering networks of neurodevelopmental genes. The extracellular availability of miRNAs allows for painless, noninvasive collection from biofluids. In this study, we investigated the potential for saliva-based miRNAs to serve as diagnostic screening tools and evaluated their potential functional importance. METHODS: Salivary miRNA was purified from 24 ASD subjects and 21 age- and gender-matched control subjects. The ASD group included individuals with mild ASD (DSM-5 criteria and Autism Diagnostic Observation Schedule) and no history of neurologic disorder, pre-term birth, or known chromosomal abnormality. All subjects completed a thorough neurodevelopmental assessment with the Vineland Adaptive Behavior Scales at the time of saliva collection. A total of 246 miRNAs were detected and quantified in at least half the samples by RNA-Seq and used to perform between-group comparisons with non-parametric testing, multivariate logistic regression and classification analyses, as well as Monte-Carlo Cross-Validation (MCCV). The top miRNAs were examined for correlations with measures of adaptive behavior. Functional enrichment analysis of the highest confidence mRNA targets of the top differentially expressed miRNAs was performed using the Database for Annotation, Visualization, and Integrated Discovery (DAVID), as well as the Simons Foundation Autism Database (AutDB) of ASD candidate genes. RESULTS: Fourteen miRNAs were differentially expressed in ASD subjects compared to controls (p <0.05; FDR <0.15) and showed more than 95 % accuracy at distinguishing subject groups in the best-fit logistic regression model. MCCV revealed an average ROC-AUC value of 0.92 across 100 simulations, further supporting the robustness of the findings. Most of the 14 miRNAs showed significant correlations with Vineland neurodevelopmental scores. Functional enrichment analysis detected significant over-representation of target gene clusters related to transcriptional activation, neuronal development, and AutDB genes. CONCLUSION: Measurement of salivary miRNA in this pilot study of subjects with mild ASD demonstrated differential expression of 14 miRNAs that are expressed in the developing brain, impact mRNAs related to brain development, and correlate with neurodevelopmental measures of adaptive behavior. These miRNAs have high specificity and cross-validated utility as a potential screening tool for ASD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Convergence of genes and cellular pathways dysregulated in autism spectrum disorders
Pinto, D., Delaby, E., Merico, D., Barbosa, M., Merikangas, A., Klei, L., Thiruvahindrapuram, B., Xu, X., Ziman, R., Wang, Z., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.03.018 · Cited by 969
Genetics of autism spectrum disorders
Geschwind, D. H. (2011) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.07.003 · Cited by 696
Weiler, I. J., Irwin, S. A., Klintsova, A. Y., Spencer, C. M., Brazelton, A. D., Miyashiro, K., Comery, T. A., Patel, B., Eberwine, J., & Greenough, W. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5395 · Cited by 644 · cited 2×
“Levels of miR-23a also fluctuate in response to CNS injuries such as cerebral ischemia [23] or temporal epilepsy [24], both of which can be associated with ASD [18].”
BackgroundCharacteristics and Concordance of Autism Spectrum Disorders Among 277 Twin Pairs
Rosenberg, R. E., Law, J. K., Yenokyan, G., McGready, J., Kaufmann, W. E., & Law, P. A. (2009) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2009.98 · Cited by 495 · cited 1×
“ASD concordance rates are 50–90 % among monozygotic twins compared with 0–30 % among dizygotic twins [4], while full siblings have a two-fold greater concordance rate than half siblings [5].”
BackgroundSFARI Gene: an evolving database for the autism research community
Banerjee-Basu, S., & Packer, A. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.005439 · Cited by 357
Wetherby, A. M., Brosnan-Maddox, S., Peace, V., & Newton, L. (2008) · Autism · doi:10.1177/1362361308094501 · Cited by 287 · cited 1×
“The ITC may be used to identify developmental deficits in children ages 9–24 months, but has limited utility in distinguishing basic communication delays from overt ASD [2].”
MethodHeterogeneous dysregulation of microRNAs across the autism spectrum
Abu-Elneel, K., Liu, T., Gazzaniga, F. S., Nishimura, Y., Wall, D. P., Geschwind, D. H., Lao, K., & Kosik, K. S. (2008) · neurogenetics · doi:10.1007/s10048-008-0133-5 · Cited by 271
Screening for autism spectrum disorders in primary care settings
Robins, D. L. (2008) · Autism · doi:10.1177/1362361308094502 · Cited by 239 · cited 1×
“Thus, the mean age of diagnosis for children with ASD is 3 years, and approximately half of these are false-positives [3].”
BackgroundIdentification of differentially expressed microRNAs across the developing human brain
Ziats, M. N., & Rennert, O. M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.93 · Cited by 214
AutismKB: an evidence-based knowledgebase of autism genetics
Xu, L.-M., Li, J.-R., Huang, Y., Zhao, M., Tang, X., & Wei, L. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr1145 · Cited by 179
Cited by
Salivary biomarkers for the diagnosis and monitoring of neurological diseases
Farah, R., Haraty, H., Salame, Z., Fares, Y., Ojcius, D. M., & Said Sadier, N. (2018) · Biomedical Journal · doi:10.1016/j.bj.2018.03.004 · Cited by 170
“[243] who was able to discover 14 differentially expressed miRNAs in ASD patient saliva when compared to healthy individuals.”
BackgroundPrata, J., Santos, S. G., Almeida, M. I., Coelho, R., & Barbosa, M. A. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0938-y · Cited by 115
A Comparative Review of microRNA Expression Patterns in Autism Spectrum Disorder
Hicks, S. D., & Middleton, F. A. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00176 · Cited by 103
“92) at differentiating control and ASD subjects (15).”
BackgroundSelf-citationBlood biomarkers for assessment of mild traumatic brain injury and chronic traumatic encephalopathy
Hiskens, M. I., Schneiders, A. G., Angoa-Pérez, M., Vella, R. K., & Fenning, A. S. (2020) · Biomarkers · doi:10.1080/1354750x.2020.1735521 · Cited by 32
“A growing number of studies show that miRNAs present in saliva may have a role in measuring changes and damage in the brain (Hicks et al. 2016, Di Pietro et al. 2018, Farah et al. 2018, Johnson et al. 2018, Hicks et al. 2018, LaRocca et al. 2019).”
Background
Metadata
- Authors
- Hicks, S. D., Ignacio, C., Gentile, K., & Middleton, F. A.
- Venue
- BMC Pediatrics
- Published
- 2016-04-22
- Volume
- 16
- Issue
- 1
- Pages
- 52-52
- ISSN
- 1471-2431 (ISSN-L)
- OpenAlex
- W2341078901
- Cited by
- 127
- References
- 14
- FWCI
- 8.42
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Salivary miRNA profiles identify children with autism spectrum disorder, correlate with adaptive behavior, and implicate ASD candidate genes involved in neurodevelopment. https://app.cochat.ai/papers/10.1186/s12887-016-0586-x
- The paper
- Hicks, S. D., Ignacio, C., Gentile, K., & Middleton, F. A. (2016). Salivary miRNA profiles identify children with autism spectrum disorder, correlate with adaptive behavior, and implicate ASD candidate genes involved in neurodevelopment. BMC Pediatrics. https://doi.org/10.1186/s12887-016-0586-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.